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Background: Colonization with MRSA is believed to have deteriorating effects on neurological rehabilitation
patients because MRSA carriers need to be isolated.
Methods: Medical records of neurological early rehabilitation patients (most of them after stroke) admitted to a
large rehabilitation facility in Northern Germany in 2010 have been carefully reviewed with respect to MRSA status,
outcome variables (functional independence), morbidity, and length of stay (LOS).
Results: 74/569 (13.0%) patients were MRSA positive on admission. MRSA carriers had a significantly longer LOS in
early neurological rehabilitation (63.7 (37.1) vs. 25.8 (24.5) days, p < 0.001), worse functional status on admission
(Barthel index (BI) 13.6 (9.9) vs. 25.6 (24.1), p < 0.001), worse Glasgow Coma Scale (9.5 (3.2) vs. 12.0 (3.3), p < 0.001),
more co-diagnoses (20.5 (5.1) vs. 13.3 (5.5), p < 0.001), and higher Patient Clinical Complexity Levels (PCCL). The
outcome was significantly worse among MRSA positive patients (BI 25.5 (21.2) vs. 47.4 (31.0), p < 0.001; Early
Rehabilitation Index −47.3 (51.4) vs. -26.0 (35.4), p < 0.001). Isolated patients had slightly less therapy per day
(131.6 (16.6) vs. 140.2 (18.7) min/day, p < 0.001), but the overall sum of therapy was significantly larger in the MRSA
positive group due to longer LOS.
Conclusions: Functional recovery of MRSA carriers in early neurological rehabilitation is worse than in MRSA
negative patients. Poorer outcome is not resulting from isolation (less therapy) but from functional status and
higher morbidity on admission.Background
Several studies suggest that colonization with methicillin
resistant Staphylococcus aureus (MRSA) is a growing
problem in rehabilitation and nursing facilities. In 1982,
the rate of MRSA colonized patients in a U. S. rehabili-
tation center was only 0.44% [1]. Eight years later, 20.6%
of veterans in a nursing home were found to be MRSA
positive (nasal colonization) [2]. A decade ago, geriatric
rehabilitation clinics have reported colonization rates
ranging from 4.8% [3] to 9.8% [4]. It has also been
shown that MRSA positive have a significantly longer
length of stay (LOS) than MRSA negative rehabilitants
[4,5]. Strict isolation of these patients is still recom-
mended [6-8] but raises ethical concerns [9]. Isolation
may cause psychological distress like depression and
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zation with MRSA, hospitalization in the past, mechanical
ventilation, antibiotic therapy, co-morbidity, tracheostomy,
renal failure, and chronic skin infections [11-13]. It is evi-
dent that neurological early rehabilitation patients carry
many of these risk factors, in particular hospitalization in-
cluding long lasting intensive care therapy, mechanical
ventilation, tracheostomy, antibiotic therapy (due to aspir-
ation pneumonia), and co-morbidity [14,15]. However,
only little data is available on MRSA incidence and preva-
lence in neurological early rehabilitation. In the BDH
Clinic Hessisch Oldendorf, we have found 6.6% MRSA
positive patients on intensive and intermediate care wards
[16], and a recent multicenter study revealed a rate of
14.5% among ten large neurological early rehabilitation fa-
cilities in Germany [17].
It is hyothesized that strict isolation due to MRSA
colonization limits rehabilitation, but there are no studies
focusing on the outcome of MRSA colonized neurological
rehabilitation patients, yet.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Main diagnoses of MRSA positive and negative
neurological early rehabilitation patients
MRSA positive MRSA negative Sum
Ischemic stroke 23 241 264
Intracranial hemorrhage 19 91 110




Brain injury 2 14 16
Brain tumour 2 14 16
Spinal injury 1 6 7
Other main diagnosis 17 102 119
Sum 74 495 569
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The BDH Clinic Hessisch Oldendorf is a neurological
hospital (including stroke unit and intensive care units)
and rehabilitation facility in Northern Germany with more
than 100 neurological early rehabilitation beds. With re-
spect to MRSA the clinic is practicing a strict “search and
destroy” strategy. All patients are systematically screened
on admission (nose and orophharynx) using a polymerase
chain reaction (PCR). If positive, a traditional culture is
done to confirm MRSA colonization. All MRSA carriers
are strictly isolated and nasal decolonization with mupiro-
cin is initiated. Isolation will be continued until three sub-
sequent samples are negative (first sample three days after
last administration of mupirocin).
To find out whether MRSA colonization has any im-
pact on outcome parameters, medical records of n = 569
neurological early rehabilitation patients admitted to the
BDH Clinic Hessisch Oldendorf in 2010 have been
reviewed. Barthel index (BI) [18], Early Rehabilitation
Barthel Index (ERBI) [19], Glasgow Coma Scale (GCS)
[20], Coma Remission Scale (CRS) [21], and Early Func-
tional Abilities (EFA) [22] on admission have been in-
cluded in the analysis. As major outcome parameters, BI
and ERBI have been recorded. In addition, length of stay
(LOS), morbidity (number of co-diagnoses and Patient
Clinical Complexity Level – PCCL [14]), and duration of
physiotherapy, ergotherapy, speech therapy, and cognitive
therapy have been analyzed.
Statistical analyses included t-tests for independent sam-
ples, univariate analyses of variance, and bivariate Pearson
correlations. Differences were regarded as significant with
p < 0.05.
Local ethics committee (BDH-Clinic Hessisch Oldendorf)
had no objections because the study was a retrospective
database analysis, only (no intervention).
Results
Among 569 neurological early rehabilitation patients (n =
304 men, n = 265 women), n=, n = 74 (13.0%) were tested
MRSA positive (nasal and/or oropharynx colonization) on
admission. All MRSA positive patients were strictly iso-
lated for a mean of 31.5 (26.7) days. Most patients admit-
ted to neurological early rehabilitation suffered from an
ischemic stroke (Table 1).
MRSA positives were not older than negative patients
and length of stay (LOS) in referring (primary) hospitals
was not different, either (Table 2). Age correlated nega-
tively with changes in BI (discharge minus admission),
r=-0.258, p<0.001, Figure 1. LOS in neurological rehabili-
tation was considerably longer among MRSA positives
(Table 2). BI, ERI, GCS, and EFA on admission were worse
in the MRSA group, and number of co-diagnoses and
PCCL among these patients were significantly higher
(Tables 2 and 3). Improvements in BI were significantlysmaller in the MRSA positive group: +11.9 (20.3) vs. +21.8
(25.7), p < 0.01.
MRSA positive neurological early rehabilitation patients
had significantly more physiotherapy and less speech and
cognitive therapy per day (Table 2). Ergotherapy did not
differ between the groups. Altogether, MRSA carriers had
about 11 min less therapy per day than negative patients
(Table 2). Because of significantly longer LOS of MRSA
positive patients, the overall sum of therapeutic proce-
dures during early rehabilitation was considerably higher
in this group.
A univariate analysis of variance was performed using
the following model: changes in BI (discharge minus ad-
mission) as dependent variable; colonization with MRSA
and PCCL as categorical independent variables; age, BI
on admission, GCS on admission, CRS on admission,
duration of isolation, physiotherapy, ergotherapy, speech
therapy, and cognitive therapy per day as independent
covariates. This model explained 69.1% of the data vari-
ation (p < 0.001). PCCL had a highly significant influence
(p < 0.001), but not MRSA colonization itself. Age (p <
0.05), physiotherapy per day (p < 0.01), and cognitive
therapy per day (p < 0.05) also had a significant influence
on changes in BI. CRS, GCS, ergotherapy, and speech
therapy did not.
Discussion
MRSA colonization is a growing problem in neurological
rehabilitation. Recent studies suggest that the prevalence
of MRSA carriers among early rehabilitation patients
ranges from 6.6% to 14.5% [16,17]. Colonization with
MRSA may limit neurological early rehabilitation because
patients need to be isolated. MRSA carriers must not par-
ticipate in group therapies which may lead to intensive
human-resource allocation and less therapy for this cohort
of rehabilitants. There are, however, no studies available
focusing on the impact of MRSA colonization on the out-
come of early rehabilitation patients, yet.
Table 2 Characteristics of MRSA positive and negative neurological early rehabilitation patients
MRSA positive MRSA negative p-value*
Age [years] 65.8 (15.1) 67.0 (15.8) n.s.
Length of stay (LOS) – referring hospital [days] 32.8 (42.9) 34.4 (260.5) n.s.
LOS – neurological early rehabilitation [days] 63.7 (37.1) 25.8 (24.5) < 0.001
LOS – entire neurological rehabilitation [days] 75.0 (42.5) 46.8 (47.1) < 0.001
Number of co-diagnoses [n] 20.5 (5.1) 13.3 (5.5) < 0.001
Barthel Index (BI) on admission [0 to 100] 13.6 (9.9) 25.6 (24.1) < 0.001
Barthel index on discharge [0 to 100] 25.5 (21.2) 47.4 (31.0) < 0.001
Early Rehabilitation Index (ERI) on admission [−325 to 0] −80.1 (59.5) −47.9 (47.6) < 0.001
ERI on discharge [−325 to 0] −47.3 (51.4) −26.0 (35.4) < 0.001
Coma Remission Scale (CRS) [0 to 24] 11.0 (6.2) 14.0 (6.8) n.s.
Glasgow Coma Scale (GCS) [3 to 15] 9.5 (3.2) 12.0 (3.3) < 0.001
Early functional abilities (EFA) – vegetative [4 to 20] 8.6 (3.0) 12.4 (7.0) < 0.001
EFA – faciooral [4 to 20] 9.2 (5.0) 15.4 (5.3) < 0.001
EFA – sensorymotor [7 to 35] 14.4 (6.9) 22.8 (8.2) < 0.001
EFA – cognitive [5 to 25] 13.3 (6.4) 18.7 (5.2) < 0.001
Physiotherapy [min/day] 42.5 (12.7) 36.6 (10.2) < 0.001
Ergotherapy [min/day] 30.3 (1.9) 31.2 (4.7) n.s.
Speech therapy [min/day] 24.1 (5.8) 27.2 (5.7) < 0.001
Cognitive therapy [min/day] 34.9 (6.1) 42.9 (9.4) < 0.001
Total main therapies [min/day] 131.6 (16.6) 140.2 (18.7) < 0.001
*t-tests for independent samples, n.s. = not significant (p > 0.05).
Figure 1 Age correlated negatively with changes in Barthel Index (discharge minus admission).
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Table 3 PCCL (Patient Clinical Complexity Level) of MRSA
positive and negative patients
MRSA Sum
Negative Positive
PCCL 0 35 0 35
1 15 0 15
2 43 3 46
3 255 10 265
4 147 61 208
Sum 495 74 569
χ2 = 78.1 (p < 0.001).
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carriers on admission to the early rehabilitation facility
which is in line with previously published results [17].
Patients had to be isolated for nearly half of their stay in
neurological early rehabilitation (31.5 days isolation vs.
63.7 days LOS early rehabilitation). This finding suggests
that decolonization procedures (local treatment with
mupirocin [6]) are successful.
It is well known that age has an impact on the outcome
of neurological patients, e.g. after stroke [23]. The present
study also demonstrated a negative correlation between
age and improvement in activities of daily living (BI) sug-
gesting that age is a risk factor for poor neurological out-
come. However, MRSA positive and negative groups did
not differ with respect to age.
In line with previous studies, MRSA positive patients
had a higher morbidity (PCCL, number of co-diagnoses),
but LOS in the referring (primary) hospital was not dif-
ferent between both groups. Functional status (Barthel
index, ERBI, CRS, EFA, GCS) was worse in the MRSA
group on admission. LOS was significantly longer among
MRSA carriers confirming previous findings [4,5].
Surprisingly, overall sum therapy was significantly larger
in the MRSA group which can be explained by longer
LOS in this cohort. Intensity of therapy (min per day),
however, was slightly smaller among MRSA carriers
(131.6 vs. 140.2 min/day). While there was even more
physiotherapy per day in the MRSA colonized group,
speech and cognitive therapy were done less frequently.
Ergotherapy did not differ. This finding suggests that
MRSA colonized patients do not necessarily receive less
therapy than MRSA negative rehabilitants. Even so, the
outcome of MRSA carriers was worse. How can this find-
ing be explained? It is well known that low functional sta-
tus on admission and co-morbidity are risk factors for
poor outcome [14,24]. It emerges from literature that BI
in the early phase is a strong predictor for long-term func-
tional outcome [24]. Poor outcome among MRSA carriers
may be explained by worse functional status on admission.
In addition, lower BI and ERBI values on admission ac-
count for longer LOS among MRSA carriers [14,25]. Thishypothesis is confirmed by a univariate analysis of vari-
ance: It turned out that BI improvement was strongly in-
fluenced by PCCL (as a measure of morbidity), age, and
BI on admission. MRSA colonization itself had no inde-
pendent influence on BI changes. Further studies on this
topic are encouraged.
Conclusions
Outcome of MRSA colonized neurological early rehabili-
tation patients is worse than functional independence of
MRSA free patients. This finding cannot be explained by
isolation effects, e.g. less therapy, but by significantly
worse functional status and morbidity of MRSA carriers
on admission.
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